
In SURMOUNT-1, 9% to 15% of people on Zepbound lost under 5% in 72 weeks. See what normal progress looks like, the common reasons tirzepatide stalls and what to ask your provider.
April Foster · November 9, 2026 · 13 min
Read More

Compare 8 Zepbound alternatives with November 2026 prices, from Zepbound for less through LillyDirect to Mounjaro, compounded tirzepatide, Wegovy, Foundayo and older pills.
April Foster · November 9, 2026 · 11 min
Read More

Yes, tirzepatide is a 39-amino-acid synthetic peptide. Learn what that means, how it's made, why it's an injection, and why the FDA warns against "research use only" vials.
April Foster · November 7, 2026 · 11 min
Read More

Zepbound is FDA-approved for moderate to severe sleep apnea in adults with obesity. See what insurers, Medicare and Medicaid require for coverage, and what it costs without insurance.
April Foster · November 7, 2026 · 12 min
Read More

Inject tirzepatide in your stomach, thigh or the back of your upper arm. See what the label and Lilly's injection-site study say about results, how to rotate, and how to inject pens and vials.
April Foster · November 7, 2026 · 11 min
Read More

There is no FDA-approved tirzepatide pill. Learn what Foundayo really is, how it compares with Zepbound, what it costs, and what the oral tirzepatide drops sold online are.
April Foster · November 7, 2026 · 11 min
Read More

Wegovy pill vs injection: the daily pill and weekly shot gave similar weight loss in trials (13.6% vs 14.9%). Compare side effects, how to take each, doses and November 2026 prices.
April Foster · November 5, 2026 · 12 min
Read More

Zepbound is Lilly's FDA-approved brand of tirzepatide, but compounded tirzepatide is a different product. Compare uses, generics, legal status and November 2026 prices.
April Foster · November 5, 2026 · 10 min
Read More

Zepbound and Mounjaro are both Eli Lilly's tirzepatide, with different FDA approvals, prices and coverage. Compare uses, doses, November 2026 costs, Medicare rules and switching.
April Foster · November 5, 2026 · 14 min
Read More